Search results
UC San Diego Health First in Region to Provide Nov | Newswise
Newswise· 2 days agoUC San Diego Health is the first hospital system in the region to offer a new immunotherapy...
Take targeted action against cancer pain
Weston Forum· 2 days agoOncologic pain is a heterogeneous phenomenon with somatic, visceral, and neural components. Effective treatment of cancer pain must take this variability...
Understanding CAR T-cell therapy: A conversation with Northside’s Dr. Melhem Solh - Atlanta Business...
The Business Journals· 2 days agoDr. Melhem Solh, medical director of the cellular therapy program at Northside Hospital, answers...
Helmer's glue: Retired IU track coach Ron, son Justin team up at Bloomington North
The Herald-Times via Yahoo Sports· 5 days ago"Then this winter, I made the comment again and it led to a little bit of discussion. Oh, maybe he...
Karyopharm to Participate at the Jefferies Global Healthcare Conference
WROC Rochester· 7 days agoKaryopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company's senior management ...
...Patients with Advanced or Recurrent TP53 Wild-Type Endometrial Cancer During 2024 ASCO Plenary...
The Pendulum· 4 days agoKaryopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced the presentation of updated exploratory ...
Questions About Melanoma? Harvard Health Publishing Has Answers.
MSN News· 3 days agoWhat are the early stages of melanoma? Answered by Dr. Howard E. Lewine M.D. Chief Medical Editor,...
Cell therapy reckoning: Pivot to autoimmune leaves unmet need in oncology
FierceBiotech· 6 days agoThis story is part 2 in a four-part series about cell therapy created by the Fierce Biotech team....
Theralase(R) Technology Effective in Virus Inactivation
Morningstar· 1 day agoThe research was completed at the laboratory of Kevin Coombs, Ph.D., University...
Molecular Templates reports progress in cancer therapy trials By Investing.com
Investing.com· 2 days agoMolecular Templates, Inc. (NASDAQ:MTEM), a clinical-stage biopharmaceutical company, has announced...